Womens Health

cfDNA Screening Shows High Accuracy for Fetal Risk Without Partner Testing

A multi-site study found cfDNA screening achieves 94.4% sensitivity for fetal risk assessment without partner testing, supporting its routine use in general-risk pregnancies.

Womens Health

New Data Supports Multi-Omic Blood Test for Early Ovarian Cancer Detection

AOA Dx presented data at AACR 2026 supporting its AKRIVIS GD Test System, a multi-omic, blood-based assay for early ovarian cancer detection in symptomatic women, reporting an AUC of 0.92 in clinical controls.

Womens Health

WHOOP Adds Women’s Health Blood Biomarker Panel to Its Lab Testing Lineup

The new panel includes 11 female-specific biomarkers covering hormonal transitions, thyroid function, and nutrient levels.

Noninvasive Prenatal Screening Could Prevent Permanent Hearing Loss in Newborns, Study Finds

Jan 7, 2026 | Prenatal Testing

Study finds noninvasive prenatal screening using low-cost whole genome sequencing can identify mothers at risk for transmitting virus that causes hearing loss in newborns.

Roche Receives CE Mark for PCR Test Targeting Bacterial Vaginosis and Candida Vaginitis

Dec 11, 2025 | Womens Health

The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.

Saliva-Based Endometriosis Test Shows 96% Accuracy

Dec 4, 2025 | Womens Health

The test uses microRNA analysis and AI to diagnose endometriosis in women with chronic pelvic pain when imaging is inconclusive.

FDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform

Nov 18, 2025 | Womens Health

The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.

Preexisting High Cholesterol in Pregnancy Linked to Elevated CV Risk

Oct 10, 2025 | Prenatal Testing

Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.

Fellow Health Joins Progyny Network for Home Male Fertility Testing

Sep 18, 2025 | Fertility Testing

Partnership provides mail-in semen analysis as a covered benefit for eligible members.

New Risk Assessment Tool Could Enhance Ovarian Cancer Detection

Sep 17, 2025 | Womens Health

The tool uses results from the CA125 blood test along with a woman’s age to generate a personalized risk score for ovarian cancer.

Natera Launches Fetal Focus Noninvasive Prenatal Test for Inherited Conditions

Aug 15, 2025 | Prenatal Testing

The new noninvasive prenatal test addresses testing gaps when biological fathers are unavailable for carrier screening by analyzing fetal DNA from maternal blood samples.

Studies Showcase Less Invasive, More Equitable Testing for Women’s Cancers

Jul 31, 2025 | Womens Health

At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.

Endometriosis Biomarker Detected by Next-Gen Tech

Jul 23, 2025 | Womens Health

Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.

Juniper Genomics Debuts Whole-Genome and Transcriptome Test

Jun 26, 2025 | Fertility Testing

Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.

Hormonal Insights for Infertility and Anovulation Care Webinar

May 27, 2025 | Fertility Testing, Webcasts

Join Tosoh Bioscience and Dr. Giuliana Puccini Santamaria for a deep dive into fertility markers and their role in diagnosing and managing infertility. This webinar explores key indicators like ovarian function, polycystic ovarian syndrome, and the importance of fast, accurate immunoassay results in fertility treatment. Ideal for clinicians seeking actionable insights in reproductive health.

Category: Womens Health

Womens Health

Womens Health

Womens Health